Think PEN-FAST: Evaluation of implementing PEN-FAST into pharmacist-led medication reconciliation
American Journal of Health-System Pharmacy · 25.04.2026
DOI: 10.1093/ajhp/zxag129 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, online erschienen am 25.04.2026. Verfasst von Samantha Linville und 4 weiteren Autor:innen. Beteiligte Einrichtung: SSM Health DePaul Hospital-St. Louis, Bridgeton, MO, USA. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Purpose
Approximately 10% of US patients report a penicillin allergy, yet fewer than 1% have a true immunoglobulin E–mediated reaction. Mislabeled allergies contribute to unnecessary use of broad-spectrum antibiotics, increasing healthcare costs, hospital stays, antimicrobial resistance, and mortality. Despite guideline recommendations for risk stratification and allergy delabeling, implementation remains limited. PEN-FAST is a validated clinical tool used to facilitate delabeling without resource-intensive skin testing. This study aimed to determine the prevalence of low-risk penicillin allergy among adult patients using the PEN-FAST tool within a pharmacist-led medication reconciliation process.
Methods
A multicenter, retrospective prevalence study was conducted at 2 community hospitals. Patients admitted or seen in the emergency department from September 16 through December 16, 2024, with a documented penicillin allergy who underwent a pharmacist-performed PEN-FAST assessment were included. The primary outcome was the proportion of patients classified as having low-risk penicillin allergy (PEN-FAST score of <3). Secondary outcomes included allergy delabeling rates and the frequency of direct oral penicillin challenges. Descriptive analysis was used to evaluate the results.
Results
Of 95 patients assessed, 74% (n = 70) were classified as low risk. Among these low-risk patients, 10% (n = 7) had their allergy label removed and 3% (n = 2) underwent a direct oral penicillin challenge, with both tolerating penicillin without adverse reactions.
Conclusion
These findings suggest that pharmacist-led PEN-FAST implementation is a feasible strategy to identify low-risk penicillin allergies, but allergy delabeling and oral challenge rates remain low. Further efforts are needed to integrate PEN-FAST into clinical workflows and enhance antimicrobial stewardship.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SSM Health DePaul Hospital-St. Louis, Bridgeton, MO, USA.
Zitieren
APA
Linville, S., Metzger, A., Etemady-Deylamy, A., Patri, M., & Rondeau, H. (2026). Think PEN-FAST: Evaluation of implementing PEN-FAST into pharmacist-led medication reconciliation. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxag129
Vancouver
Linville S, Metzger A, Etemady-Deylamy A, Patri M, Rondeau H. Think PEN-FAST: Evaluation of implementing PEN-FAST into pharmacist-led medication reconciliation. American Journal of Health-System Pharmacy. 2026. doi:10.1093/ajhp/zxag129
BibTeX
@article{Linville2026,
author = {Linville, Samantha and Metzger, Alex and Etemady-Deylamy, Ali and Patri, Manokiran and Rondeau, Hunter},
title = {Think PEN-FAST: Evaluation of implementing PEN-FAST into pharmacist-led medication reconciliation},
journal = {American Journal of Health-System Pharmacy},
year = {2026},
doi = {10.1093/ajhp/zxag129}
}
EUVIMED